工艺装备AU申请中

Ganaxolone For Use In Treating Genetic Epileptic Disorders

Ask AI about this

查看原文 ↗

申请人Marinus Pharmaceuticals, Inc.

发明人Jaakko Lappalainen

公开号AU2024227357A1

申请日2024-10-15

公开日2024-10-31

摘要

The disclosure provides a method of treating a mammal having a genetic epileptic disorder, comprising chronically administering a pharmaceutically acceptable pregnenolone neurosteroid to a mammal having a genetic epileptic disorder in an amount effective to reduce the seizure frequency in the …

Ganaxolone For Use In Treating Genetic Epileptic Disorders

摘要

相关专利